EDGE joins the fight against the COVID-19 pandemic with the development of the Observation of National Epidemics (ONE) System. This system allows the monitoring of the symptoms of COVID-19 patients and individuals under active surveillance at home, as well as the sharing of this information, upon the individual’s consent, with the medical team that follows on the treatment, enabling them to monitor in near real time the evolution of the patients’ condition and to act promptly should a patient’s symptoms worsen by requesting the patient’s immediate hospitalisation.
Through an easy-to-use and friendly App, COVID-19 patients and the individuals under active surveillance or quarantine register their temperature, their symptoms (cough, respiratory problems, headache, body pain, tiredness), including the severity level, and their wellbeing status. With the patients’ authorisation, the information is sent to the ONE Platform at the point of care (hospital, health centre or health authority) that is responsible for accompanying the patients. The medical team has therefore access to the health and wellbeing condition of each patient at any time and may not only accompany the evolution of the patients’ conditions, but also early identify the worrisome situations with a hospitalisation risk and act accordingly, in a fast and articulated manner with the involved hospitals.
With 80% of the COVID-19 infected patients conducting their treatment at home, the ONE System facilitates the remote follow-up of these patients by their medical teams, through the remote monitoring of their symptoms and of their health and wellbeing condition, which is a highly scalable response that supports the delivery of care to thousands of patients simultaneously and in an effective and efficient way, contributing to flatten the infection curve, to reduce the transmission rate, to limit the spread of the contagion and to diminish the pressure on hospitals and health centres, thus supporting the management of hospital admissions and preventing deaths.